McCullumsmith Robert E, Gupta Daya, Beneyto Monica, Kreger Emily, Haroutunian Vahram, Davis Kenneth L, Meador-Woodruff James H
Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
Schizophr Res. 2007 Feb;90(1-3):15-27. doi: 10.1016/j.schres.2006.11.017. Epub 2007 Jan 12.
Several recent studies have found changes in the expression of genes functionally related to myelination and oligodendrocyte homeostasis in schizophrenia. These studies utilized microarrays and quantitative PCR (QPCR), methodologies which do not permit direct, unamplified examination of mRNA expression. In addition, these studies generally only examined transcript expression in homogenates of gray matter. In the present study, we examined the expression of myelination-related genes previously implicated in schizophrenia by microarray or QPCR. Using in situ hybridization, we measured transcript expression of 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP), myelin-associated glycoprotein (MAG), transferrin (TF), quaking (QKI), gelsolin, myelin oligodendrocyte glycoprotein, v-erb-b2 erythroblastic leukemia viral oncogene homolog 3, erbb2 interacting protein, motility-related protein-1, SRY-box containing gene 10, oligodendrocyte transcription factor 2, peripheral myelin protein 22, and claudin-11 in both gray and white matter of the anterior cingulate cortex (ACC) in subjects with schizophrenia (n=41) and a comparison group (n=34). We found decreased expression of MAG, QKI, TF, and CNP transcripts in white matter. We did not find any differences in expression of these transcripts between medicated (n=31) and unmedicated (n=10) schizophrenics, suggesting that these changes are not secondary to treatment with antipsychotics. Finally, we found significant positive correlations between QKI and MAG or CNP mRNA expression, suggesting that the transcription factor QKI regulates MAG and CNP expression. Our results support the hypothesis that myelination and oligodendrocyte function are impaired in schizophrenia.
最近的几项研究发现,精神分裂症患者中与髓鞘形成和少突胶质细胞稳态功能相关的基因表达发生了变化。这些研究使用了微阵列和定量PCR(QPCR)技术,这些方法无法直接、未经扩增地检测mRNA表达。此外,这些研究通常只检测了灰质匀浆中的转录本表达。在本研究中,我们检测了先前通过微阵列或QPCR发现与精神分裂症有关的髓鞘形成相关基因的表达。我们使用原位杂交技术,测量了2',3'-环核苷酸3'-磷酸二酯酶(CNP)、髓鞘相关糖蛋白(MAG)、转铁蛋白(TF)、震颤蛋白(QKI)、凝溶胶蛋白、髓鞘少突胶质细胞糖蛋白、v-erb-b2成红细胞白血病病毒癌基因同源物3、erbb2相互作用蛋白、运动相关蛋白-1、含SRY盒基因10、少突胶质细胞转录因子2、外周髓鞘蛋白22和闭合蛋白-11在精神分裂症患者(n=41)和对照组(n=34)前扣带回皮质(ACC)的灰质和白质中的转录本表达。我们发现白质中MAG、QKI、TF和CNP转录本的表达降低。我们没有发现服药(n=31)和未服药(n=10)的精神分裂症患者之间这些转录本的表达有任何差异,这表明这些变化不是抗精神病药物治疗的继发结果。最后,我们发现QKI与MAG或CNP mRNA表达之间存在显著正相关,这表明转录因子QKI调节MAG和CNP的表达。我们的结果支持了精神分裂症患者髓鞘形成和少突胶质细胞功能受损这一假说。